Literature DB >> 15671925

Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments.

W K Redekop1, E A Stolk, E Kok, K Lovas, Z Kalo, J J V Busschbach.   

Abstract

OBJECTIVES: Diabetic foot ulcers (DFU), infections and amputations are associated with high costs of care and loss of health. To evaluate new treatments, both the extra costs incurred and the health utility gained need to be examined. However, evaluations of treatments in diabetes are hampered by the lack of utility values for health states such as DFU. We estimated utility values for health states seen amongst DFU patients.
METHODS: We identified 13 unique health states based on presence/type of DFU and amputation. Members of the general public (n=107) received a description of each health state. They were then asked to indicate how undesirable each health state was (using the time trade-off method). Each answer was then transformed to create a value representing the "utility" of the health state, the utility value represented on a 0-1 scale.
RESULTS: Valid responses could be obtained from 96 persons. Mean values included: 0.84 (diabetes with no DFU or amputation), 0.75 (uninfected DFU, no amputation), 0.68 (no DFU, previous foot amputation), and 0.63 (uninfected DFU, previous amputation of other foot). The impact of an ulcer depended on amputation status.
CONCLUSIONS: Our values correspond with previously published results but are more detailed. In addition, since our values were derived from the general public, economic evaluations that incorporate them will use the generally preferred societal perspective. Therefore, these values are appropriate, practical and sensitive weights to calculate QALYs for cost-effectiveness analyses of foot ulcer treatments.

Entities:  

Mesh:

Year:  2004        PMID: 15671925     DOI: 10.1016/s1262-3636(07)70154-4

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  26 in total

1.  Economic evaluation of Vacuum Assisted Closure® Therapy for the treatment of diabetic foot ulcers in France.

Authors:  Sarah J Whitehead; Véronique L Forest-Bendien; Jean-Louis Richard; Serge Halimi; Georges Ha Van; Paul Trueman
Journal:  Int Wound J       Date:  2010-09-28       Impact factor: 3.315

2.  A cost-effectiveness analysis of optimal care for diabetic foot ulcers in Australia.

Authors:  Qinglu Cheng; Peter A Lazzarini; Michelle Gibb; Patrick H Derhy; Ewan M Kinnear; Edward Burn; Nicholas Graves; Rosana E Norman
Journal:  Int Wound J       Date:  2016-08-04       Impact factor: 3.315

3.  Chronic wound repair and healing in older adults: current status and future research.

Authors:  Lisa Gould; Peter Abadir; Harold Brem; Marissa Carter; Teresa Conner-Kerr; Jeff Davidson; Luisa DiPietro; Vincent Falanga; Caroline Fife; Sue Gardner; Elizabeth Grice; John Harmon; William R Hazzard; Kevin P High; Pamela Houghton; Nasreen Jacobson; Robert S Kirsner; Elizabeth J Kovacs; David Margolis; Frances McFarland Horne; May J Reed; Dennis H Sullivan; Stephen Thom; Marjana Tomic-Canic; Jeremy Walston; Jo Anne Whitney; John Williams; Susan Zieman; Kenneth Schmader
Journal:  J Am Geriatr Soc       Date:  2015-03-06       Impact factor: 5.562

4.  Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model.

Authors:  Fay Crawford; Francesca M Chappell; James Lewsey; Richard Riley; Neil Hawkins; Donald Nicolson; Robert Heggie; Marie Smith; Margaret Horne; Aparna Amanna; Angela Martin; Saket Gupta; Karen Gray; David Weller; Julie Brittenden; Graham Leese
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

5.  Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy.

Authors:  B Rodríguez-Sánchez; L M Peña-Longobardo; A J Sinclair
Journal:  Eur J Health Econ       Date:  2019-11-12

6.  The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers.

Authors:  Elbert S Huang; Qi Zhang; Sydney E S Brown; Melinda L Drum; David O Meltzer; Marshall H Chin
Journal:  Health Serv Res       Date:  2007-12       Impact factor: 3.402

7.  Chronic wound repair and healing in older adults: current status and future research.

Authors:  Lisa Gould; Peter Abadir; Harold Brem; Marissa Carter; Teresa Conner-Kerr; Jeff Davidson; Luisa DiPietro; Vincent Falanga; Caroline Fife; Sue Gardner; Elizabeth Grice; John Harmon; William R Hazzard; Kevin P High; Pamela Houghton; Nasreen Jacobson; Robert S Kirsner; Elizabeth J Kovacs; David Margolis; Frances McFarland Horne; May J Reed; Dennis H Sullivan; Stephen Thom; Marjana Tomic-Canic; Jeremy Walston; JoAnne Whitney; John Williams; Susan Zieman; Kenneth Schmader
Journal:  Wound Repair Regen       Date:  2015-02-13       Impact factor: 3.617

8.  Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease.

Authors:  Stefano de Franciscis; Luca Gallelli; Luigi Battaglia; Vincenzo Molinari; Rossella Montemurro; Domenico M Stillitano; Gianluca Buffone; Raffaele Serra
Journal:  Int Wound J       Date:  2013-05-15       Impact factor: 3.315

9.  The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis.

Authors:  Elbert S Huang; Qi Zhang; Niren Gandra; Marshall H Chin; David O Meltzer
Journal:  Ann Intern Med       Date:  2008-07-01       Impact factor: 25.391

Review 10.  Management and prevention of diabetic foot ulcers and infections: a health economic review.

Authors:  Ivy Chow; Elkin V Lemos; Thomas R Einarson
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.